Financial reports
10-K
2011 FY
Annual report
2 Mar 12
10-Q
2011 Q3
Quarterly report
8 Nov 11
10-Q
2011 Q2
Quarterly report
5 Aug 11
10-Q
2011 Q1
Quarterly report
10 May 11
ARS
2010 FY
Annual report to shareholders
6 May 11
10-K/A
2010 FY
Annual report (amended)
15 Apr 11
10-K
2010 FY
Annual report
4 Mar 11
10-Q
2010 Q3
Quarterly report
9 Nov 10
10-Q
2010 Q2
Quarterly report
6 Aug 10
10-K/A
2009 FY
Annual report (amended)
20 Jul 10
Current reports
8-K
Completion of Acquisition or Disposition of Assets
7 Mar 12
8-K
Entry into a Material Definitive Agreement
27 Jan 12
8-K
Micromet Reports Third Quarter 2011 Financial Results
8 Nov 11
8-K
Q2 2011 earnings press release
4 Aug 11
8-K/A
Submission of Matters to a Vote of Security Holders
28 Jul 11
8-K
Micromet Announces Solid Tumor BiTE Antibody Collaboration with Amgen
15 Jul 11
8-K
Amendments to Articles of Incorporation or Bylaws
28 Jun 11
8-K
Departure of Directors or Certain Officers
16 Jun 11
8-K
Micromet Reports First Quarter 2011 Financial Results and Highlights
10 May 11
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4 Apr 11
Registration and prospectus
AW
Withdrawal of amendment
20 Mar 12
15-12G
Securities registration termination
19 Mar 12
RW
Registration withdrawal request
14 Mar 12
D
$175.46M in equity, sold $175.46M, 1 investor
12 Mar 12
POS AM
Prospectus update (post-effective amendment)
12 Mar 12
POS AM
Prospectus update (post-effective amendment)
12 Mar 12
POS AM
Prospectus update (post-effective amendment)
12 Mar 12
POS AM
Prospectus update (post-effective amendment)
12 Mar 12
POS AM
Prospectus update (post-effective amendment)
12 Mar 12
POS AM
Prospectus update (post-effective amendment)
12 Mar 12
Proxies
DEFA14A
Additional proxy soliciting materials
6 May 11
DEF 14A
Definitive proxy
29 Apr 11
DEFA14A
Additional proxy soliciting materials
14 Jun 10
DEF 14A
Definitive proxy
30 Apr 10
DEF 14A
Definitive proxy
30 Apr 09
DEFA14A
Additional proxy soliciting materials
30 Apr 09
DEF 14A
Definitive proxy
29 Apr 08
DEFA14A
Additional proxy soliciting materials
29 Apr 08
DEF 14A
Definitive proxy
30 Apr 07
DEF 14A
Definitive proxy
28 Apr 05
Other
EFFECT
Notice of effectiveness
14 Mar 12
EFFECT
Notice of effectiveness
14 Mar 12
EFFECT
Notice of effectiveness
14 Mar 12
EFFECT
Notice of effectiveness
14 Mar 12
EFFECT
Notice of effectiveness
14 Mar 12
EFFECT
Notice of effectiveness
14 Mar 12
EFFECT
Notice of effectiveness
14 Mar 12
EFFECT
Notice of effectiveness
14 Mar 12
EFFECT
Notice of effectiveness
14 Mar 12
EFFECT
Notice of effectiveness
14 Mar 12
Ownership
SC 13D
AMGEN INC
3 Feb 12
SC 13D/A
Omega Fund Management LTD
25 Feb 10
SC 13D/A
Alvarez-Masterton Sharon Rose
25 Feb 10
SC 13D/A
Alvarez-Masterton Sharon Rose
9 Feb 10
SC 13D/A
Omega Fund Management LTD
9 Feb 10
SC 13D/A
Omega Fund Management LTD
29 Jan 10
SC 13D/A
Alvarez-Masterton Sharon Rose
29 Jan 10